Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
74
BSTZ Quote, Financials, Valuation and Earnings
Last price:
$22.86
Seasonality move
:
-10.58%
Day range:
$22.80 - $23.01
52-week range:
$15.22 - $23.30
Dividend yield:
10.77%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
80.6K
Avg. volume:
183.3K
1-year change:
5.1%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
BSTZ
BlackRock Science and Technology Term Trust
|
-- | -- | -- | -- | -- |
|
AIO
Virtus Artificial Intelligence & Technology Opportunities Fund
|
-- | -- | -- | -- | -- |
|
BST
BlackRock Science and Technology Trust
|
-- | -- | -- | -- | -- |
|
BTX
Brooklyn ImmunoTherapeutics
|
-- | -- | -- | -- | -- |
|
NBXG
Neuberger Next Generation Connectivity Fund Inc.
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
BSTZ
BlackRock Science and Technology Term Trust
|
$22.86 | -- | -- | -- | $0.52 | 10.77% | -- |
|
AIO
Virtus Artificial Intelligence & Technology Opportunities Fund
|
$23.17 | -- | -- | -- | $1.19 | 7.77% | -- |
|
BST
BlackRock Science and Technology Trust
|
$39.98 | -- | -- | -- | $1.45 | 7.5% | -- |
|
BTX
Brooklyn ImmunoTherapeutics
|
-- | -- | -- | -- | $0.00 | 0% | -- |
|
NBXG
Neuberger Next Generation Connectivity Fund Inc.
|
$14.56 | -- | -- | -- | $0.12 | 8.65% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
BSTZ
BlackRock Science and Technology Term Trust
|
-- | 1.783 | -- | -- |
|
AIO
Virtus Artificial Intelligence & Technology Opportunities Fund
|
-- | 1.756 | -- | -- |
|
BST
BlackRock Science and Technology Trust
|
-- | 1.608 | -- | -- |
|
BTX
Brooklyn ImmunoTherapeutics
|
-- | 0.000 | -- | -- |
|
NBXG
Neuberger Next Generation Connectivity Fund Inc.
|
-- | 1.566 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
BSTZ
BlackRock Science and Technology Term Trust
|
-- | -- | -- | -- | -- | -- |
|
AIO
Virtus Artificial Intelligence & Technology Opportunities Fund
|
-- | -- | -- | -- | -- | -- |
|
BST
BlackRock Science and Technology Trust
|
-- | -- | -- | -- | -- | -- |
|
BTX
Brooklyn ImmunoTherapeutics
|
-- | -- | -- | -- | -- | -- |
|
NBXG
Neuberger Next Generation Connectivity Fund Inc.
|
-- | -- | -- | -- | -- | -- |
BlackRock Science and Technology Term Trust vs. Competitors
-
Which has Higher Returns BSTZ or AIO?
Virtus Artificial Intelligence & Technology Opportunities Fund has a net margin of -- compared to BlackRock Science and Technology Term Trust's net margin of --. BlackRock Science and Technology Term Trust's return on equity of -- beat Virtus Artificial Intelligence & Technology Opportunities Fund's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BSTZBlackRock Science and Technology Term Trust-- -- -- AIOVirtus Artificial Intelligence & Technology Opportunities Fund-- -- -- -
What do Analysts Say About BSTZ or AIO?
BlackRock Science and Technology Term Trust has a consensus price target of --, signalling downside risk potential of --. On the other hand Virtus Artificial Intelligence & Technology Opportunities Fund has an analysts' consensus of -- which suggests that it could fall by --. Given that BlackRock Science and Technology Term Trust has higher upside potential than Virtus Artificial Intelligence & Technology Opportunities Fund, analysts believe BlackRock Science and Technology Term Trust is more attractive than Virtus Artificial Intelligence & Technology Opportunities Fund.
Company Buy Ratings Hold Ratings Sell Ratings BSTZBlackRock Science and Technology Term Trust0 0 0 AIOVirtus Artificial Intelligence & Technology Opportunities Fund0 0 0 -
Is BSTZ or AIO More Risky?
BlackRock Science and Technology Term Trust has a beta of 1.528, which suggesting that the stock is 52.804% more volatile than S&P 500. In comparison Virtus Artificial Intelligence & Technology Opportunities Fund has a beta of 1.227, suggesting its more volatile than the S&P 500 by 22.74%.
-
Which is a Better Dividend Stock BSTZ or AIO?
BlackRock Science and Technology Term Trust has a quarterly dividend of $0.52 per share corresponding to a yield of 10.77%. Virtus Artificial Intelligence & Technology Opportunities Fund offers a yield of 7.77% to investors and pays a quarterly dividend of $1.19 per share. BlackRock Science and Technology Term Trust pays -- of its earnings as a dividend. Virtus Artificial Intelligence & Technology Opportunities Fund pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BSTZ or AIO?
BlackRock Science and Technology Term Trust quarterly revenues are --, which are smaller than Virtus Artificial Intelligence & Technology Opportunities Fund quarterly revenues of --. BlackRock Science and Technology Term Trust's net income of -- is lower than Virtus Artificial Intelligence & Technology Opportunities Fund's net income of --. Notably, BlackRock Science and Technology Term Trust's price-to-earnings ratio is -- while Virtus Artificial Intelligence & Technology Opportunities Fund's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BlackRock Science and Technology Term Trust is -- versus -- for Virtus Artificial Intelligence & Technology Opportunities Fund. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BSTZBlackRock Science and Technology Term Trust-- -- -- -- AIOVirtus Artificial Intelligence & Technology Opportunities Fund-- -- -- --
-
Which has Higher Returns BSTZ or BST?
BlackRock Science and Technology Trust has a net margin of -- compared to BlackRock Science and Technology Term Trust's net margin of --. BlackRock Science and Technology Term Trust's return on equity of -- beat BlackRock Science and Technology Trust's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BSTZBlackRock Science and Technology Term Trust-- -- -- BSTBlackRock Science and Technology Trust-- -- -- -
What do Analysts Say About BSTZ or BST?
BlackRock Science and Technology Term Trust has a consensus price target of --, signalling downside risk potential of --. On the other hand BlackRock Science and Technology Trust has an analysts' consensus of -- which suggests that it could fall by --. Given that BlackRock Science and Technology Term Trust has higher upside potential than BlackRock Science and Technology Trust, analysts believe BlackRock Science and Technology Term Trust is more attractive than BlackRock Science and Technology Trust.
Company Buy Ratings Hold Ratings Sell Ratings BSTZBlackRock Science and Technology Term Trust0 0 0 BSTBlackRock Science and Technology Trust0 0 0 -
Is BSTZ or BST More Risky?
BlackRock Science and Technology Term Trust has a beta of 1.528, which suggesting that the stock is 52.804% more volatile than S&P 500. In comparison BlackRock Science and Technology Trust has a beta of 1.331, suggesting its more volatile than the S&P 500 by 33.133%.
-
Which is a Better Dividend Stock BSTZ or BST?
BlackRock Science and Technology Term Trust has a quarterly dividend of $0.52 per share corresponding to a yield of 10.77%. BlackRock Science and Technology Trust offers a yield of 7.5% to investors and pays a quarterly dividend of $1.45 per share. BlackRock Science and Technology Term Trust pays -- of its earnings as a dividend. BlackRock Science and Technology Trust pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BSTZ or BST?
BlackRock Science and Technology Term Trust quarterly revenues are --, which are smaller than BlackRock Science and Technology Trust quarterly revenues of --. BlackRock Science and Technology Term Trust's net income of -- is lower than BlackRock Science and Technology Trust's net income of --. Notably, BlackRock Science and Technology Term Trust's price-to-earnings ratio is -- while BlackRock Science and Technology Trust's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BlackRock Science and Technology Term Trust is -- versus -- for BlackRock Science and Technology Trust. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BSTZBlackRock Science and Technology Term Trust-- -- -- -- BSTBlackRock Science and Technology Trust-- -- -- --
-
Which has Higher Returns BSTZ or BTX?
Brooklyn ImmunoTherapeutics has a net margin of -- compared to BlackRock Science and Technology Term Trust's net margin of --. BlackRock Science and Technology Term Trust's return on equity of -- beat Brooklyn ImmunoTherapeutics's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BSTZBlackRock Science and Technology Term Trust-- -- -- BTXBrooklyn ImmunoTherapeutics-- -- -- -
What do Analysts Say About BSTZ or BTX?
BlackRock Science and Technology Term Trust has a consensus price target of --, signalling downside risk potential of --. On the other hand Brooklyn ImmunoTherapeutics has an analysts' consensus of -- which suggests that it could fall by --. Given that BlackRock Science and Technology Term Trust has higher upside potential than Brooklyn ImmunoTherapeutics, analysts believe BlackRock Science and Technology Term Trust is more attractive than Brooklyn ImmunoTherapeutics.
Company Buy Ratings Hold Ratings Sell Ratings BSTZBlackRock Science and Technology Term Trust0 0 0 BTXBrooklyn ImmunoTherapeutics0 0 0 -
Is BSTZ or BTX More Risky?
BlackRock Science and Technology Term Trust has a beta of 1.528, which suggesting that the stock is 52.804% more volatile than S&P 500. In comparison Brooklyn ImmunoTherapeutics has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock BSTZ or BTX?
BlackRock Science and Technology Term Trust has a quarterly dividend of $0.52 per share corresponding to a yield of 10.77%. Brooklyn ImmunoTherapeutics offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. BlackRock Science and Technology Term Trust pays -- of its earnings as a dividend. Brooklyn ImmunoTherapeutics pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BSTZ or BTX?
BlackRock Science and Technology Term Trust quarterly revenues are --, which are smaller than Brooklyn ImmunoTherapeutics quarterly revenues of --. BlackRock Science and Technology Term Trust's net income of -- is lower than Brooklyn ImmunoTherapeutics's net income of --. Notably, BlackRock Science and Technology Term Trust's price-to-earnings ratio is -- while Brooklyn ImmunoTherapeutics's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BlackRock Science and Technology Term Trust is -- versus -- for Brooklyn ImmunoTherapeutics. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BSTZBlackRock Science and Technology Term Trust-- -- -- -- BTXBrooklyn ImmunoTherapeutics-- -- -- --
-
Which has Higher Returns BSTZ or NBXG?
Neuberger Next Generation Connectivity Fund Inc. has a net margin of -- compared to BlackRock Science and Technology Term Trust's net margin of --. BlackRock Science and Technology Term Trust's return on equity of -- beat Neuberger Next Generation Connectivity Fund Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BSTZBlackRock Science and Technology Term Trust-- -- -- NBXGNeuberger Next Generation Connectivity Fund Inc.-- -- -- -
What do Analysts Say About BSTZ or NBXG?
BlackRock Science and Technology Term Trust has a consensus price target of --, signalling downside risk potential of --. On the other hand Neuberger Next Generation Connectivity Fund Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that BlackRock Science and Technology Term Trust has higher upside potential than Neuberger Next Generation Connectivity Fund Inc., analysts believe BlackRock Science and Technology Term Trust is more attractive than Neuberger Next Generation Connectivity Fund Inc..
Company Buy Ratings Hold Ratings Sell Ratings BSTZBlackRock Science and Technology Term Trust0 0 0 NBXGNeuberger Next Generation Connectivity Fund Inc.0 0 0 -
Is BSTZ or NBXG More Risky?
BlackRock Science and Technology Term Trust has a beta of 1.528, which suggesting that the stock is 52.804% more volatile than S&P 500. In comparison Neuberger Next Generation Connectivity Fund Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock BSTZ or NBXG?
BlackRock Science and Technology Term Trust has a quarterly dividend of $0.52 per share corresponding to a yield of 10.77%. Neuberger Next Generation Connectivity Fund Inc. offers a yield of 8.65% to investors and pays a quarterly dividend of $0.12 per share. BlackRock Science and Technology Term Trust pays -- of its earnings as a dividend. Neuberger Next Generation Connectivity Fund Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BSTZ or NBXG?
BlackRock Science and Technology Term Trust quarterly revenues are --, which are smaller than Neuberger Next Generation Connectivity Fund Inc. quarterly revenues of --. BlackRock Science and Technology Term Trust's net income of -- is lower than Neuberger Next Generation Connectivity Fund Inc.'s net income of --. Notably, BlackRock Science and Technology Term Trust's price-to-earnings ratio is -- while Neuberger Next Generation Connectivity Fund Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BlackRock Science and Technology Term Trust is -- versus -- for Neuberger Next Generation Connectivity Fund Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BSTZBlackRock Science and Technology Term Trust-- -- -- -- NBXGNeuberger Next Generation Connectivity Fund Inc.-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
72
GLTO alert for Dec 27
Galecto, Inc. [GLTO] is up 16.92% over the past day.
Sell
20
SMX alert for Dec 27
SMX (Security Matters) Plc [SMX] is down 15.76% over the past day.
Sell
11
CDNAF alert for Dec 27
Canadian Tire Corp. Ltd. [CDNAF] is down 10% over the past day.
